International Journal of Head and Neck Surgery

Register      Login

VOLUME 9 , ISSUE 2 ( April-June, 2018 ) > List of Articles


Laryngeal Dysplasia: What does the Evidence Tell Us?

Anusha Balasubramanian, Vinidh Paleri

Keywords : Carcinoma-in Situ, Dysplasia, Laryngeal, Leukoplakia, Vocal fold

Citation Information : Balasubramanian A, Paleri V. Laryngeal Dysplasia: What does the Evidence Tell Us?. Int J Head Neck Surg 2018; 9 (2):87-93.

DOI: 10.5005/jp-journals-10001-1341

License: CC BY-NC 4.0

Published Online: 01-03-2017

Copyright Statement:  Copyright © 2018; The Author(s).


Management of laryngeal dysplasia often poses a clinical conundrum, especially so with its unpredictable propensity for malignant transformation. The wide heterogeneity in published results and the dearth of level I evidence makes it challenging to arrive at a consensus or best practice guidelines. In 2010, ENT UK had developed such a guideline based on critical analysis of previously published data and professional opinion. This article examines the available evidence, and attempts to highlight the best possible modalities in investigation and management strategies as objectively as possible.

PDF Share
  1. Warnakulasuriya S, Reibel J, Bouquot J, Dabelsteen E. Oral epithelial dysplasia classification systems: predictive value, utility, weaknesses and scope for improvement. J Oral Pathol Med 2008 Mar;37(3):127-133.
  2. Ferlito A, Devaney KO, Woolgar JA, Slootweg PJ, Paleri V, Takes RP, Strojan P, Bradley PJ, Rinaldo A. Squamous epithelial changes of the larynx: diagnosis and therapy. Head Neck 2012 Dec;34(12):1810-1816.
  3. Barnes L, Eveson JW, Reichart P, Sidransky D. World Health Organization Classification of Tumours. Pathology and Genetics of Tumours of the Head and Neck. IARC Press, Lyon; ed 2005.
  4. Bouquot J, Gnepp D. Laryngeal precancer: a review of the literature, commentary, and comparison with oral leukoplakia. Head Neck 1991;13:488-497.
  5. Weller MD, Nankivell PC, McConkey C, Paleri V, Mehanna HM. The risk and interval to malignancy of patients with laryngeal dysplasia; a systematic review of case series and metaanalysis. Clin Otolaryngol 2010 Oct;35(5):364-372.
  6. Ahn A, Wang L, Slaughter JC, Nguyen AM, Ossoff RH, Francis DO. Serial Full-Thickness Excision of Dysplastic Vocal Fold Leukoplakia: Diagnostic or Therapeutic?. Laryngoscope 2016 Apr;126(4):923-927.
  7. McLaren KM, Burnett RA, Goodlad JR, Howatson SR, Lang S, Lee FD, et al. Consistency of histopathological reporting of laryngeal dysplasia. The Scottish pathology consistency group. Histopathology. 2000;37(5):460-463.
  8. Fleskens SA, Bergshoeff VE, Voogd AC, van Velthuysen ML, Bot FJ, Speel EJ, et al. Interobserver variability of laryngeal mucosal premalignant lesions: a histopathological evaluation. Mod Pathol. 2011;24(7):892-898.
  9. Gale N, Poljak M, Zidar N. Update from the 4th Edition of the World Health Organization Classification of Head and Neck Tumours: What is New in the 2017 WHO Blue Book for Tumours of the Hypopharynx, Larynx, Trachea and Parapharyngeal Space. Head Neck Pathol. 2017 Mar;11(1):23-32.
  10. Gale N, Gnepp DR, Poljak M, Strojan P, Cardesa A, Helliwell T, et al. Laryngeal squamous intraepithelial lesions: an updated review on etiology, classification, molecular changes, and treatment. Adv Anat Pathol. 2016;23(2):84-91.
  11. Mehanna H, Paleri V, Robson A, Wight R, Helliwell T. Consensus statement by otorhinolaryngologists and pathologists on the diagnosis and management of laryngeal dysplasia. Clin Otolaryngol 2010 Jun;35(3):170-176.
  12. Cosway B, Drinnan M, Paleri V. Narrow band imaging for the diagnosis of head and neck squamous cell carcinoma: A systematic review. Head Neck 2016 Apr;38 Suppl 1:E2358-2367.
  13. De Vito A, Meccariello G, Vicini C. Narrow band imaging as screening test for early detection of laryngeal cancer: a prospective study. Clin Otolaryngol 2017Apr;42(2):347-353.
  14. Kraft M, Fostiropoulos K, Gürtler N, Arnoux A, Davaris N, Arens C.Value of narrow band imaging in the early diagnosis of laryngeal cancer. Head Neck 2016Jan;38(1):15-20.
  15. Cosway B, Paleri V. Laryngeal dysplasia: an evidence-based flowchart to guide management and follow up. J Laryngol Otol 2015 Jun;129(6):598-599.
  16. Staníková L, Šatanková J, Kuèová H, Walderová R, Zeleník K, Komínek P. The role of narrow-band imaging (NBI) endoscopy in optical biopsy of vocal cord leukoplakia. Eur Arch Otorhinolaryngol 2017Jan;274(1):355-359.
  17. Paleri V, Sawant R, Mehanna H, Ainsworth H, Stocken D. Laryngeal Dysplasia and narrow band imaging: secondary analysis of published data supports the role in patient follow up. Clin Otolaryngol (in press)
  18. Schweinfurth JM, Powitzky E, Ossoff RH. Regression of laryngeal dysplasia after serial microflap excision. Ann Otol Rhinol Laryngol 2001;110:811-814.
  19. Kono T, Saito K, Yabe H, Ogawa K. Phonosurgical resection using submucosal infusion technique for precancerous laryngeal leukoplakia. Laryngoscope 2017 Jan;127(1):153-158.
  20. Koufman JA, Rees CJ, Frazier WD, Kilpatrick LA, Wright SC, Halum SL, et al. Office-based laryngeal laser surgery: a review of 443 cases using three wavelengths. Otolaryngol Head Neck Surg 2007Jul;137(1):146-151.
  21. Yan Y, Olszewski AE, Hoffman MR, Zhuang P, Ford CN, Dailey SH, et al. Use of Lasers in Laryngeal Surgery. J Voice 2010 Jan;24(1):102-109.
  22. Franco JRA Jr. In-office laryngeal surgery with the 585-nm pulsed dye laser. Curr Opin Otolaryngol Head Neck Surg 2007Dec;15(6):387-393.
  23. Koss SL, Baxter P, Panossian H, Woo P, Pitman MJ. Serial inoffice laser treatment of vocal fold leukoplakia: Disease control and voice outcomes. Laryngoscope 2017Jul;127(7):1644-1651.
  24. Del Signore AG, Shah RN, Gupta N, Altman KW, Woo P. Complications and Failures of Office-Based Endoscopic Angiolytic Laser Surgery Treatment. J Voice 2016Nov;30(6):744-750.
  25. Rodrigo JP, García-Carracedo D, García LA, Menéndez S, Allonca E, González MV, et al. Distinctive clinicopathological associations of amplification of the cortactin gene at 11q13 in head and neck squamous cell carcinomas. J Pathol 2009Mar;217(4):516-523.
  26. Papadimitrakopoulou V, Izzo JG, Liu DD, Myers J, Ceron TL, Lewin J, et al. Cyclin D1 and cancer development in laryngeal premalignancy patients. Cancer Prev Res 2009Jan;2(1):14-21.
  27. Mirza S, Jeannon JP, Soames J, Wilson JA. Is Ki67 a marker for the transformation of laryngeal dysplasia to carcinoma?. Acta Oto-Laryngol 2006Apr;126(4):418-422.
  28. Nankivell P, Weller M, McConkey C, Paleri V, Mehanna H. Biomarkers in laryngeal dysplasia:a systematic review. Head Neck 2011Aug;33(8):1170-1176.
  29. Nowiñska K, Ciesielska U, Podhorska-Okołów M, Dziêgiel P. The role of human papillomavirus in oncogenic transformation and its contribution to the etiology of precancerous lesions and cancer of the larynx: A review. Adv Clin Exp Med 2017 May-Jun;26(3):539-547.
  30. Gallo, A, Degener, AM, Pagliuca, G. Detection of human papillomavirus and adenovirus in benign and malignant lesions of the larynx. Otolaryngol Head Neck Surg. 2009 Aug;141(2): 276-281.
  31. Waters HH, Seth R, Hoschar AP, Benninger MS. Does HPV have a presence in diffuse high grade pre-malignant lesions of the larynx? Laryngoscope 2010;120 Suppl 4:S201.
  32. Pagliuca G, Martellucci S, Degener AM, Pierangeli A, Greco A, Fusconi M, et al. Role of Human Papillomavirus in the Pathogenesis of Laryngeal Dysplasia. Otolaryngol Head Neck Surg 2014 Jun;150(6):1018-1023.
  33. Boffetta P, Hashibe M. Alcohol and cancer. Lancet Oncol 2006 Feb;7(2):149-156.
  34. Bagnardi V, Rota M, Botteri E, Tramacere I, Islami F, Fedirko V, et al. Alcohol consumption and site-specific cancer risk: a comprehensive dose-response meta-analysis. Br J Cancer 2015Feb 3;112(3):580-593.
  35. Theodosiou MG, Yiotakis J, Dikoglou C, Lazaris AC, Athanasiadis- Sismanis A, Xenellis J. Laryngeal dysplasia: a long-term follow-up study. J BUON 2013Jul-Sep;18(3):683-688.
  36. Galli J, Volante GCM, Corso ED, Almadori G, Paludetti G. Laryngeal carcinoma and laryngo-pharyngeal reflux disease. Acta Otorhinolaryngol Ital. 2006 Oct; 26(5): 260–263.
  37. William WN Jr, Hong WK, Lippman SM. Chemoprevention of Cancer: Epidemiology, Prevention and Detection. In: Robert C. Bast, Jr., Carlo M. Croce, William N. Hait, Waun Ki Hong, Donald W. Kufe, Martine Piccart-Gebhart, Raphael E. Pollock, Ralph R. Weichselbaum, Hongyang Wang, James F. Holland. Holland-Frei Cancer Medicine. 9th ed. John Wiley & Sons; 2017.
  38. Califano J, Westra WH, Meininger G, Corio R, Koch WM, Sidransky D. Genetic progression and clonal relationship of recurrent premalignant head and neck lesions. Clin Cancer Res 2000 Feb;6(2):347-352.
  39. Mesolella M, Iengo M, Testa D, Ricciardiello F, Iorio B. Chemoprevention using folic acid for dysplastic lesions of the larynx. Mol Clin Oncol 2017Nov;7(5):843-846.
PDF Share
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.